News Genetic Analysis

Equities

GEAN

NO0010692130

End-of-day quote NORDIC GROWTH MARKET Other stock markets 06:00:00 2024-04-18 pm EDT			5-day change	1st Jan Change
0.54 ^NOK	-0.37%		-61.70%	-36.47%

Feb. 29	Genetic Analysis AS Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI
Feb. 26	Genetic Analysis AS Announces CE-IVD Marking for its GA-map Sample Collection Kit	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Genetic Analysis AS: Mandatory notification of trade - Primary Insider	Apr. 19	AQ
Genetic Analysis AS: Publication of Annual Report 2023	Apr. 18	AQ
Genetic Analysis AS: Mandatory notification of trade - Primary Insider	Mar. 11	AQ
Year-end report January - December 2023	Feb. 29	AQ
Genetic Analysis AS Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 29	CI
Genetic Analysis AS: Genetic Analysis AS announces CE-IVDR marking for its GA-map® Sample Collection Kit	Feb. 26	AQ
Genetic Analysis AS Announces CE-IVD Marking for its GA-map Sample Collection Kit	Feb. 26	CI
Genetic Analysis subsequent offering to existing shareholders has now been registered with the Norwegian Register of Business Enterprises	Jan. 10	AQ
Genetic Analysis announces final outcome of the subsequent offering to existing shareholders	Dec. 27	AQ
Genetic Analysis announces preliminary outcome of the subsequent offering to existing shareholders	Dec. 22	AQ
Genetic Analysis partners up to enter the consumer market with GA-map®	Dec. 21	AQ
Genetic Analysis Partners Up to Enter the Consumer Market with Ga-Map	Dec. 21	CI
Genetic Analysis summarizes this year's product development activities and looks ahead to 2024	Dec. 13	AQ
Today, the subscription period in Genetic Analysis subsequent offering begins	Dec. 11	AQ
Genetic Analysis publishes information memorandum relating to the previously announced subsequent offering	Dec. 08	AQ
Genetic Analysis announces final number of subscription rights received per existing share in the previously announced subsequent offering	Dec. 08	AQ
Genetic Analysis announces terms of the previously announced subsequent offering to shareholders of up to appr. NOK 9 million	Nov. 30	AQ
Genetic Analysis AS: Mandatory notification of trade	Nov. 20	AQ
Genetic Analysis AS: Minutes from the Extraordinary General Meeting	Nov. 20	AQ
Presentation of GA-map® by Genetic Analysis sparks great interest at xMAP® Connect EMEA in Amsterdam	Nov. 16	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Genetic Analysis

Equities

GEAN

NO0010692130

Summary

Filters